Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022

SELL
$101.65 - $119.27 $198,522 - $232,934
-1,953 Reduced 7.49%
24,130 $2.52 Million
Q2 2022

Aug 15, 2022

BUY
$102.23 - $133.85 $112,146 - $146,833
1,097 Added 4.39%
26,083 $2.74 Million
Q1 2022

May 16, 2022

BUY
$108.42 - $129.58 $886,984 - $1.06 Million
8,181 Added 48.68%
24,986 $3.2 Million
Q4 2021

Feb 14, 2022

BUY
$115.43 - $146.63 $466,337 - $592,385
4,040 Added 31.65%
16,805 $2.14 Million
Q3 2021

Nov 15, 2021

SELL
$136.35 - $158.76 $95,308 - $110,973
-699 Reduced 5.19%
12,765 $1.87 Million
Q1 2021

May 14, 2021

SELL
$148.16 - $159.71 $337,064 - $363,340
-2,275 Reduced 14.45%
13,464 $2.16 Million
Q4 2020

Feb 16, 2021

SELL
$128.25 - $151.41 $41,937 - $49,511
-327 Reduced 2.04%
15,739 $2.43 Million
Q3 2020

Nov 13, 2020

SELL
$113.59 - $141.68 $175,950 - $219,462
-1,549 Reduced 8.79%
16,066 $2.19 Million
Q2 2020

Aug 14, 2020

BUY
$87.02 - $133.4 $1.53 Million - $2.35 Million
17,615 New
17,615 $2.1 Million

Others Institutions Holding ZBH

About ZIMMER BIOMET HOLDINGS, INC.


  • Ticker ZBH
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 209,820,000
  • Market Cap $23.3B
  • Description
  • Zimmer Biomet Holdings, Inc., together with its subsidiaries, operates in the musculoskeletal healthcare business in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company designs, manufactures, and markets orthopaedic reconstructive products, such as knee and hip products; S.E.T. products, including sports medicine, bi...
More about ZBH
Track This Portfolio

Track Capital International, Inc. Portfolio

Follow Capital International, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Capital International, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Capital International, Inc. with notifications on news.